ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Xilis Raises $70 Million Series A Financing to Advance Diagnostic and Drug Discovery and Development Platform Leveraging Proprietary MicroOrganoSphere Technology
July 09, 2021Xilis, Inc., a pioneering company using its MicroOrganoSphere (MOS) technology to guide precision therapy for cancer patients and accelerate drug discovery and development, today announced the close of a $70 million Series A financing. -
Sofinnova, LSP lead $17M round for gene therapy player XyloCor
December 29, 2018XyloCor Therapeutics raised $17 million in its series A round to advance a gene therapy pipeline for cardiovascular disease. Its lead asset is a treatment for angina that is poised to enter the clinic in 2019....
Pharma Sources Insight January 2025
